Muhammad Ashraf, Ph.D.

SUPERVISORY CHEMIST
US Food and Drug Administration

Poster(s):

• (W1030-10-56) Validation and Application of an LC-MS/MS Method to Evaluate In Vitro Permeation of Naloxone Nasal Spray Using Artificial Substrate
  Wednesday, October 23, 2024

  10:30 AM – 11:30 AM MT

• (T1130-09-49) Development of In Vitro Skin Permeation Testing Method to Assess the Bioequivalence of Topical Roflumilast Cream Formulations
  Tuesday, October 22, 2024

  11:30 AM – 12:30 PM MT

• (W1130-09-50) Assessment of In Vitro Skin Permeation of Ruxolitinib of OPZELURA (Ruxolitinib Phosphate) Topical Cream, EQ 1.5% Base to Support a Demonstration of Bioequivalence
  Wednesday, October 23, 2024

  11:30 AM – 12:30 PM MT

• (W1130-10-56) Mechanistic Evaluation of Microstructure and Performance Attributes of Medicated Topical Shampoos
  Wednesday, October 23, 2024

  11:30 AM – 12:30 PM MT

• (M1330-10-55) Evaluation of Critical Microstructural and Performance Attributes of Azelaic Acid Topical Gels
  Monday, October 21, 2024

  1:30 PM – 2:30 PM MT